New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2014
06:37 EDTBLUEbluebird bio price target raised to $58 from $51 at Piper Jaffray
Piper Jaffray raised its price target for bluebird bio (BLUE) shares to $58 saying the beta thal market provides opportunity for both bluebird and Biogen (BIIB). Piper sees a possible market split should both companies' data remain positive. It keeps an Overweight rating on bluebird bio.
News For BLUE From The Last 14 Days
Check below for free stories on BLUE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for BLUE

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use